ViGenCell Inc. (KOSDAQ:308080)
South Korea · Delayed Price · Currency is KRW 7,950.00
0.00 (0.00%)
At close: Feb 19, 2026
ViGenCell Market Cap
ViGenCell has a market cap or net worth of 162.97 billion as of February 20, 2026. Its market cap has increased by 229.18% in one year.
Market Cap
162.97B
Enterprise Value
125.68B
Revenue
278.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
7,950.00
Market Cap Chart
Since August 25, 2021, ViGenCell's market cap has decreased from 561.23B to 162.97B, a decrease of -70.96%. That is a compound annual growth rate of -24.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 162.97B | -18.46% |
| Dec 30, 2025 | 199.87B | 315.01% |
| Dec 30, 2024 | 48.16B | -57.05% |
| Dec 28, 2023 | 112.12B | -17.15% |
| Dec 29, 2022 | 135.32B | -61.11% |
| Dec 30, 2021 | 347.95B | -38.00% |
| Aug 25, 2021 | 561.23B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prestige Biologics | 221.98B |
| ISU Abxis | 219.90B |
| Vaxcell-Bio Therapeutics | 217.69B |
| QuadMedicine | 208.91B |
| Bio Solution | 205.95B |
| Ensol Biosciences | 202.80B |
| Kangstem Biotech | 196.10B |
| TiumBio | 175.63B |